Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis

Yang, S; Zhao, L; Mi, YC; He, W

Yang, S (通讯作者),China Med Univ, Dept Endocrinol & Metab, Peoples Hosp, Peoples Hosp Liaoning Prov, Shenyang 110013, Liaoning, Peoples R China.

DIABETES OBESITY & METABOLISM, 2022; 24 (11): 2159

Abstract

Aims To compare the efficacy of sodium-glucose cotransporter-2 (SGLT2) inhibitors, nonsteroidal mineralocorticoid receptor antagonists (MRAs), selecti......

Full Text Link